Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 42 of 42

Filter Applied: controversies in neurology (Click to remove)

Rethinking the Role of Tube Feeding in Patients with Advanced Dementia
NEJM 342:206-210, Gillick,M.R., 2000

Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 384:970-971, , 2021

Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
NEJM 384:2081-2091,2154, Whitlock, R.P.,et al, 2021

Anticoagulation after Ablation for Atrial Fibrillation
NEJM 385:466-468, Kadire, S.R., 2021

Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention
Neurol 94:876-885, Messe, S.R.,et al, 2020

Evidence-Based Management of Patent Foramen Ovale in Patients with Ischemic Stroke
JAMA Neurol 75:147-148, Kamel, H., 2018

PFO Closure for Cryptogenic Stroke
NEJM 378:1639-1642, Mi, M.Y.,et al, 2018

Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation Therapy Alone for Management of Cryptogenic Stroke?
BMJ 362:k2515, Kuijpers, T.,et al, 2018

Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017

Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke
NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017

Hydrocephalus in Children
Lancet 387:788-799, Kahle, K.T.,et al, 2016

Closure Versus Medical Therapy for Preventing Recurrent Stroke in Patients with Patent Foramen Ovale and a History of Cryptogenic Stroke or Transient Ischemic Attack
Stroke 47:e188-e189, Li, J.,et al, 2016

Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013

Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
NEJM 368:1083-1091,1152, Meier, B.,et al, 2013

Management of Antithrombotic Therapy in Patients Undergoing Invasive Procedures
NEJM 368:2113-2124, Baron, T.,et al, 2013

Patent Foramen Ovale and Cryptogenic Stroke
Stroke 44:2676-2678, Furlan, A.J. and Jauss, M., 2013

Left Atrial Catheter Ablation and Ischemic Stroke
Stroke 43:265-270, Haeusler, K.G.,et al, 2012

Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012

Critique of Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
Stroke 43:3147-3149, Thaler, D.E.,et al, 2012

Minimally Invasive Surgery for Spontaneous Supratentorial Intracerebral Hemorrhage
Stroke 43:2923-2930, Zhou, X.,et al, 2012

Study Design of the CLOSURE I Trial: A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients With Stroke or TIA Due to Presumed Paradoxical Embolism Through a PFO
Stroke 41:2872-2883, Furlan,A.J.,et al, 2010

A 70-Year-Old Man With a Transient Ischemic Attack: Review of Internal Carotid Artery Stenosis
JAMA 300:81-89, Caplan,L.R., 2008

Carotid Stenting for Patients with Coexisting Carotid and Coronary Disease
Arch Neurol 65:1670-1672,1675, Xavier,A.R. &Chaturvedi,S., 2008

Middle Cerebral Artery Stenosis: Stenting Is One of the Options: Yes
Stroke 38:1418-1419,1422, Liu,M.,et al, 2007

Middle Cerebral Artery Stenosis: Stenting Is One of the Options: No
Stroke 38:1420-1421,1422, Kasner,S.E., 2007

Percutaneous Laser Disk Decompression: A Review of the Literature
AJNR 27:232-235, Schenck,B.,et al, 2006

Angioplasty With or Without Stenting for Intracranial Artery Stenosis
Stroke 37: 2858-2859, Cruz-Flores,S. &Diamond,A.L., 2006

Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial Fibrillation
Circulation 114:759-765, Oral,H.,et al, 2006

Simultaneous Carotid Endarterectomy and Coronary Artery Bypass Surgery in Canada
Neurol 64:1435-1437,1332, Hill,M.D.,et al, 2005

Patent Foramen Ovale Closure Devices
JAMA 294:366-369, Maisel,W.H.&Laskey,W.K., 2005

Patent Foramen Ovale in Young Adults with Unexplained Stroke
NEJM 353:2361-2372, Kizer,J.R. &Devereux,R.B., 2005

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004

Incidence and Clinical Course of Thrombus Formation on Atrial Septal Defect and Patent Foramen Ovale Closure Devices in 1,000 Consecutive Patients
J Am Coll Cardiol 43:302-309, Krumsdorf,U.,et al, 2004

Angioplasty and Stenting for Stroke Prevention, Good Questions That Need Answers
Neurol 59:664-668, Chaturvedi,S.&Fessler,R., 2002

Angioplasty and Stenting Should be Performed Only in the Setting of a Clinical Trial
Stroke 33:2519-2523, Brott,T.G., 2002

Angioplasty or Stenting is Not Appropriate as First-Line Treatment of Intracranial Stenosis
Arch Neurol 58:1690-1692, Chimowitz,M.I., 2001

Angioplasty and Stenting for Primary Treatment of Intracranial Arterial Stenoses
Arch Neurol 58:1687-1690,1692, Gomez,C.R. &Orr,S.C., 2001

Treatment of Atherosclerotic Disease at the Cervical Carotid Bifurcation: Current Status and Review of the Literature
AJNR 21:444-450, Connors III,J.J.,et al, 2000

Carotid Angioplasty:In Search of a Worthy Alternative to Endarterectomy
Arch Neurol 53:696-698, 7001996., Ferguson,R.D.G.&Ferguson,J.G., 1996

Angioplasty for Carotid Disease
Arch Neurol 53:698-700, Ferguson,G.G., 1996

How Should a Patient Presenting with Unstable Angina and a Recent Stroke be Managed?
BMJ 310:1449-1452, Davenport,R.J.,et al, 1995



Showing articles 0 to 42 of 42